Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Acid Stimulation of the Citrate Transporter NaDC-1 Requires Pyk2 and ERK1/2 Signaling Pathways.

Zacchia M, Tian X, Zona E, Alpern RJ, Preisig PA.

J Am Soc Nephrol. 2018 Jun;29(6):1720-1730. doi: 10.1681/ASN.2017121268. Epub 2018 Apr 20.

2.

Tough decisions about protocol review.

Preisig PA, Silverman J, Brown P, Petervary N.

Lab Anim (NY). 2017 Jun 23;46(7):290-294. doi: 10.1038/laban.1300. No abstract available.

PMID:
28644450
3.

The role of the IACUC in ensuring research reproducibility.

Silverman J, Macy J, Preisig PA.

Lab Anim (NY). 2017 Mar 22;46(4):129-135. doi: 10.1038/laban.1213. Review.

PMID:
28328872
4.

Response to protocol review scenario: One wrong, one right.

Preisig PA, Macy JD.

Lab Anim (NY). 2015 Mar;44(3):87-8. doi: 10.1038/laban.705. No abstract available.

PMID:
25693102
5.

Response to Protocol Review Scenario: Not so fast.

Preisig PA, Fusco KA.

Lab Anim (NY). 2014 Mar;43(3):81. doi: 10.1038/laban.478. No abstract available.

PMID:
24552907
6.

Drosophila: a fruitful model for calcium oxalate nephrolithiasis?

Knauf F, Preisig PA.

Kidney Int. 2011 Aug;80(4):327-9. doi: 10.1038/ki.2011.166.

7.

Acid regulation of NaDC-1 requires a functional endothelin B receptor.

Liu L, Zacchia M, Tian X, Wan L, Sakamoto A, Yanagisawa M, Alpern RJ, Preisig PA.

Kidney Int. 2010 Nov;78(9):895-904. doi: 10.1038/ki.2010.264. Epub 2010 Aug 11.

8.

Biochemical and histological assessment of alkali therapy during high animal protein intake in the rat.

Zerwekh JE, Zou L, Pak CY, Moe OW, Preisig PA.

Bone. 2009 Nov;45(5):1004-9. doi: 10.1016/j.bone.2009.07.077. Epub 2009 Aug 6.

9.

The acid-activated signaling pathway: starting with Pyk2 and ending with increased NHE3 activity.

Preisig PA.

Kidney Int. 2007 Dec;72(11):1324-9. Epub 2007 Sep 19. Review.

10.

RhoA required for acid-induced stress fiber formation and trafficking and activation of NHE3.

Yang X, Huang HC, Yin H, Alpern RJ, Preisig PA.

Am J Physiol Renal Physiol. 2007 Oct;293(4):F1054-64. Epub 2007 Aug 8.

11.

Dietary acid, endothelins, and sleep.

Alpern RJ, Preisig PA.

Trans Am Clin Climatol Assoc. 2004;115:385-93; discussion 393-4.

12.

Dual role of citrate in mammalian urine.

Moe OW, Preisig PA.

Curr Opin Nephrol Hypertens. 2006 Jul;15(4):419-24. Review. No abstract available.

PMID:
16775456
13.

Hypothesizing on the evolutionary origins of salt-induced hypercalciuria.

Moe OW, Preisig PA.

Curr Opin Nephrol Hypertens. 2005 Jul;14(4):368-72. Review. No abstract available.

PMID:
15931006
14.

Pyk2 activation is integral to acid stimulation of sodium/hydrogen exchanger 3.

Li S, Sato S, Yang X, Preisig PA, Alpern RJ.

J Clin Invest. 2004 Dec;114(12):1782-9.

15.

A consensus sequence in the endothelin-B receptor second intracellular loop is required for NHE3 activation by endothelin-1.

Laghmani K, Sakamoto A, Yanagisawa M, Preisig PA, Alpern RJ.

Am J Physiol Renal Physiol. 2005 Apr;288(4):F732-9. Epub 2004 Dec 14.

16.

An autocrine role for endothelin-1 in the regulation of proximal tubule NHE3.

Licht C, Laghmani K, Yanagisawa M, Preisig PA, Alpern RJ.

Kidney Int. 2004 Apr;65(4):1320-6.

17.

OKP cells express the Na-dicarboxylate cotransporter NaDC-1.

Aruga S, Pajor AM, Nakamura K, Liu L, Moe OW, Preisig PA, Alpern RJ.

Am J Physiol Cell Physiol. 2004 Jul;287(1):C64-72. Epub 2004 Feb 18.

18.

Effect of high protein diet on stone-forming propensity and bone loss in rats.

Amanzadeh J, Gitomer WL, Zerwekh JE, Preisig PA, Moe OW, Pak CY, Levi M.

Kidney Int. 2003 Dec;64(6):2142-9.

19.
20.

Role of c-SRC and ERK in acid-induced activation of NHE3.

Tsuganezawa H, Sato S, Yamaji Y, Preisig PA, Moe OW, Alpern RJ.

Kidney Int. 2002 Jul;62(1):41-50.

21.

The role of endothelin in proximal tubule proton secretion and the adaptation to a chronic metabolic acidosis.

Laghmani K, Preisig PA, Alpern RJ.

J Nephrol. 2002 Mar-Apr;15 Suppl 5:S75-87. Review.

PMID:
12027224
22.

Endothelin-1/endothelin-B receptor-mediated increases in NHE3 activity in chronic metabolic acidosis.

Laghmani K, Preisig PA, Moe OW, Yanagisawa M, Alpern RJ.

J Clin Invest. 2001 Jun;107(12):1563-9.

23.

Bouncing the question from the whole animal to the test tube and back.

Preisig PA, Moe OW.

Curr Opin Nephrol Hypertens. 2001 May;10(3):405-7. No abstract available.

PMID:
11342805
24.

ET(B) receptor activation causes exocytic insertion of NHE3 in OKP cells.

Peng Y, Amemiya M, Yang X, Fan L, Moe OW, Yin H, Preisig PA, Yanagisawa M, Alpern RJ.

Am J Physiol Renal Physiol. 2001 Jan;280(1):F34-42.

25.

A better understanding of the kidney in health and disease: what will it take?

Moe OW, Preisig PA.

Curr Opin Nephrol Hypertens. 2000 Jul;9(4):381-4. Review. No abstract available.

PMID:
10926174
26.

Acid incubation causes exocytic insertion of NHE3 in OKP cells.

Yang X, Amemiya M, Peng Y, Moe OW, Preisig PA, Alpern RJ.

Am J Physiol Cell Physiol. 2000 Aug;279(2):C410-9.

27.

Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney.

Aruga S, Wehrli S, Kaissling B, Moe OW, Preisig PA, Pajor AM, Alpern RJ.

Kidney Int. 2000 Jul;58(1):206-15.

29.

Renal citrate metabolism and urinary citrate excretion in the infant rat.

Melnick JZ, Preisig PA, Alpern RJ, Baum M.

Kidney Int. 2000 Mar;57(3):891-7.

30.

Size does matter: will knockout of p21(WAF1/CIP1) save the kidney by limiting compensatory renal growth?

Al-Awqati Q, Preisig PA.

Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10551-3. Review. No abstract available.

31.

ETB receptor activation leads to activation and phosphorylation of NHE3.

Peng Y, Moe OW, Chu T, Preisig PA, Yanagisawa M, Alpern RJ.

Am J Physiol. 1999 Apr;276(4):C938-45. doi: 10.1152/ajpcell.1999.276.4.C938.

PMID:
10199826
32.

Glucocorticoids enhance acid activation of the Na+/H+ exchanger 3 (NHE3).

Ambühl PM, Yang X, Peng Y, Preisig PA, Moe OW, Alpern RJ.

J Clin Invest. 1999 Feb;103(3):429-35.

33.

Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia.

Melnick JZ, Preisig PA, Haynes S, Pak CY, Sakhaee K, Alpern RJ.

Kidney Int. 1998 Nov;54(5):1670-4.

34.

Dominant negative c-Src inhibits angiotensin II induced activation of NHE3 in OKP cells.

Tsuganezawa H, Preisig PA, Alpern RJ.

Kidney Int. 1998 Aug;54(2):394-8.

35.

Renal cortical mitochondrial aconitase is regulated in hypo- and hypercitraturia.

Melnick JZ, Preisig PA, Moe OW, Srere P, Alpern RJ.

Kidney Int. 1998 Jul;54(1):160-5.

36.

Chronic hyperosmolality increases NHE3 activity in OKP cells.

Ambühl P, Amemiya M, Preisig PA, Moe OW, Alpern RJ.

J Clin Invest. 1998 Jan 1;101(1):170-7.

37.

Media acidification inhibits TGF beta-mediated growth suppression in cultured rabbit proximal tubule cells.

Tovbin D, Franch HA, Alpern RJ, Preisig PA.

Proc Assoc Am Physicians. 1997 Nov;109(6):572-9.

PMID:
9394419
38.

Adenosine triphosphate citrate lyase mediates hypocitraturia in rats.

Melnick JZ, Srere PA, Elshourbagy NA, Moe OW, Preisig PA, Alpern RJ.

J Clin Invest. 1996 Nov 15;98(10):2381-7.

39.

Chronic metabolic acidosis increases NHE3 protein abundance in rat kidney.

Ambühl PM, Amemiya M, Danczkay M, Lötscher M, Kaissling B, Moe OW, Preisig PA, Alpern RJ.

Am J Physiol. 1996 Oct;271(4 Pt 2):F917-25.

PMID:
8898023
40.

NH4Cl-induced hypertrophy is mediated by weak base effects and is independent of cell cycle processes.

Franch HA, Preisig PA.

Am J Physiol. 1996 Mar;270(3 Pt 1):C932-8.

PMID:
8638677
41.

Chronic regulation of the proximal tubular Na/H antiporter: from HCO3 to SRC.

Alpern RJ, Moe OW, Preisig PA.

Kidney Int. 1995 Nov;48(5):1386-96. Review. No abstract available.

42.

Overexpression of csk inhibits acid-induced activation of NHE-3.

Yamaji Y, Amemiya M, Cano A, Preisig PA, Miller RT, Moe OW, Alpern RJ.

Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6274-8.

43.

Renal epithelial cell hyperplasia and hypertrophy.

Preisig PA, Franch HA.

Semin Nephrol. 1995 Jul;15(4):327-40. Review.

PMID:
7569412
44.

Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy.

Franch HA, Shay JW, Alpern RJ, Preisig PA.

J Cell Biol. 1995 Apr;129(1):245-54.

45.

Angiotensin II stimulation of Na-H antiporter activity is cAMP independent in OKP cells.

Cano A, Miller RT, Alpern RJ, Preisig PA.

Am J Physiol. 1994 Jun;266(6 Pt 1):C1603-8.

PMID:
8023891
46.

Chronic regulation of the Na/H antiporter.

Alpern RJ, Yamaji Y, Cano A, Horie S, Miller RT, Moe OW, Preisig PA.

J Lab Clin Med. 1993 Aug;122(2):137-40. Review.

PMID:
8393472
47.

Luminal flow rate regulates proximal tubule H-HCO3 transporters.

Preisig PA.

Am J Physiol. 1992 Jan;262(1 Pt 2):F47-54.

PMID:
1310229
48.

Chronic K depletion stimulates rat renal brush-border membrane Na-citrate cotransporter.

Levi M, McDonald LA, Preisig PA, Alpern RJ.

Am J Physiol. 1991 Nov;261(5 Pt 2):F767-73.

PMID:
1683169
49.

Differential regulation of Na/H antiporter by acid in renal epithelial cells and fibroblasts.

Moe OW, Miller RT, Horie S, Cano A, Preisig PA, Alpern RJ.

J Clin Invest. 1991 Nov;88(5):1703-8.

50.

Chronic adaptations in proximal tubular H/HCO3 transporters.

Alpern RJ, Horie S, Moe O, Tejedor A, Miller RT, Preisig PA.

Kidney Int Suppl. 1991 Jul;33:S29-32. Review.

PMID:
1653870

Supplemental Content

Loading ...
Support Center